Cipla will announce its Q2 FY26 results on October 30. Analysts expect a steady quarter supported by healthy growth in the India and South Africa businesses, even as the US segment continues to face headwinds from gRevlimid tapering and persistent price erosion in the base portfolio. Margins are likely to remain stable in the 24.5 to 26.5 percent range, aided by operating discipline and a favourable product mix.

A Moneycontrol poll of five brokerages pegs Cipla’s revenue growth at 5 to 6 percent year-on-year to around Rs 7,300 to 7,450 crore. EBITDA is expected between Rs 1,824 and Rs 1,932 crore, implying margins of about 25 percent, broadly flat compared with the previous quarter. Net profit is seen in the Rs 1,266 to 1,630 crore range, depending on forex movement and tax adjustments.

See Full Page